By Bageshri Banerjee

(Reuters) -Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

The company, which makes medical implants to repair broken bones and replace joints like hips and knees, now expects full-year profit in the range of $13.50 to $13.60 per share, compared with its previous forecast of $13.40 to $13.60 per share.

Investor expectations around medical device makers have grown in recent quarters as they expect them to benefit from elevated demand for surgical procedures, as more older patients opt for medical procedures deferred during the pandemic.

However, analysts at Truist Securities warned that if the overall knee market is shrinking,

See Full Page